Open in interactive viewer → charts, metric popovers & call review

Wienerberger Stops Waiting for the Recovery — and Puts the Dividend on the Table

A three-month-old CEO, two profit warnings and €2.4bn of net debt turn a patient cyclical story into a leverage-and-portfolio story
WIE.VI · Earnings Call · 2026-11-12

The winter that will not end

For two years Wienerberger sold investors a simple hedge: yes, European new-build was terrible, but renovation and infrastructure were close to 60% of revenue and would carry the group through. On this call, that hedge broke. Gerhard Hanke, confirmed as CEO the day before, opened with the uncomfortable version: “It was not only the demand in the residential or in the new residential construction, which has slowed down. But in general, we have seen a weaker market demand across all end markets, so also including the renovation and the infrastructure sector.” — Gerhard Hanke, Chief Executive Officer · 2026-11-12 The quarter itself was modest but not the point: revenue around €1.3bn, operating EBITDA down from €202m to €180m, a margin near 14%, volumes off 6% against pricing up 6%, and the punchline was the second guidance cut of the year — from the €700m set in July to €640–650m. Net debt sat at €2.4bn at end-September against a €2.2bn year-end target, implying 3.3–3.4x leverage. That is the number everything else in this call is organised around.

What management stopped saying

Two keywords that dominated this company's vocabulary for six straight quarters have quietly vanished from the top of the deck. Price cost was the single highest-ranked theme in Q2 2026 and a fixture in 2025 — the entire bull case rested on price/cost flipping positive. It is now absent, because the answer is known and it was not good: 8% cost inflation against 6% pricing in Q3, plus the cost of running plants half-empty. Fit for Growth, the cost programme the CFO defended quarter after quarter, has been folded into a new and much larger performance enhancement program: €140m of run-rate earnings improvement by end-2028, ~€80m by end-2027, and "at least €25m" of incremental EBITDA in 2027 — a figure management itself called conservative before delivering anything. Most telling is the fate of the mid-term ambition. In August, the CEO was unambiguous: “Yes, we confirm the EUR 1 billion. It is linked to the recovery of new housing in Europe and in the U.S. mainly.” — Gerhard Hanke, CEO · 2026-08-12 Three months later the same man says there will be no real major recovery in new build, interest rates are rising again, and that planning for a recovery is a reason not to scrap capacity — not a reason to guide to one. The €1bn target has not been formally retracted. It has simply stopped being mentioned, which is what a shelved target looks like.

You know it that the ROCE is around about 7%, 8%, which is much too low by having a back of a cost of capital of around 10%. So this is the exercise, really walk through countries.

Gerhard Hanke, Chief Executive Officer · 2026-11-12

The €10m promise that became €70–80m

Credibility questions in this dossier are not abstract. In the August Q&A, asked about restructuring one-offs for the second half, Hanke said: “we will see some of the one-offs, but I would say maximum to EUR 10 million one-off of restructuring.” — Dagmar Steinert, CFO · 2026-08-12 The current guidance is €70–80m of restructuring charges in Q4 alone, half of it cash out in the first half of 2027, tied to plant network optimisation and mothballing European capacity. That is an eight-fold restatement in one quarter, and it is the clearest evidence that the strategic review is producing a harder, less flattering picture than the pre-review language did. To be fair to the new team, this is precisely what a cold-eyed review is supposed to do — the CEO admits the company is not where it wants to be and promises to be measured against delivery. But an investor should note the pattern: guidance cut in October, mid-term target gone quiet, one-off estimate up eight-fold, and now a strategic review whose conclusions arrive on 4 March 2027.

Where the capital actually goes

The three stated priorities — debt reduction, financial performance, and returns on invested capital — collapse into one. Growth M&A is paused, new growth capex is frozen, and the portfolio analysis covers "every business without any exceptions", with peripheral facades and Western European masonry named as the soft spots. The Italcer second instalment (~€160m) is being actively pushed into a later year. And then the line that matters most to income holders, buried at the back of the Q&A on a question read from the chat box: “when we speak about capital allocation, we speak about CapEx projects, we speak about M&A. We have commented on these 2 things. And yes, dividend, especially our dividend policy, we are also looking at that.” — Gerhard Hanke, Chief Executive Officer · 2026-11-12 The dividend policy has never been in play in the twelve quarters of this conversation. It is now. At a €2.1bn market cap, with the equity already discounting a cyclical trough, a dividend reset is the difference between owning a levered recovery and owning a deleveraging exercise.

The tape is voting on someone else's recovery

Here is the contrast that matters. Over the last 30 days the market has been quietly bidding up the American housing-repair complex — Lowe's, Home Depot and Kingfisher all up strongly on home improvement market optimism and talk of "signs of life" — while Ferguson, the US plumbing and HVAC distributor, reported on new residential construction in the very same window. That recovery is real, but it is American and it is distribution-led. Wienerberger's own disclosure makes the point sharper: North American volumes were "comparatively stable", while the weakness was most pronounced in Europe West, including the UK. The company is not short of exposure to a US upturn; it is short of a European one, and the tape is not voting on Europe. Layer on management's own observation that rising interest rate environments are back and the geographic mismatch becomes the core of the equity story. The 10% cost of capital against a 7–8% ROCE is ultimately an interest-rate problem before it is an operational one, which is why the 4 March event — debt reduction plan, 2027 EBITDA guidance, portfolio conclusions, and the one-off cost envelope, all at once — will be the single densest disclosure this company has produced in years.

Bottom line

This is not a turnaround with a visible trajectory; it is a turnaround with a calendar. Everything genuinely decision-shaped — what gets sold, what gets mothballed, what the dividend becomes, and what 2027 earnings look like under a lower capacity base — has been deferred to a single March morning. What we can say today is that the language has changed materially: from defending a mid-term €1bn ambition and a neutral price/cost spread, to a company admitting its returns sit 200–300bp below its cost of capital and that even the shareholder distribution is under review. That is a more honest call than any of the last four, and a considerably less comfortable one.